First Time Loading...

Astellas Pharma Inc
TSE:4503

Watchlist Manager
Astellas Pharma Inc Logo
Astellas Pharma Inc
TSE:4503
Watchlist
Price: 1 558 JPY 2.16% Market Closed
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one Astellas Pharma Inc stock under the Base Case scenario is 2 850.74 JPY. Compared to the current market price of 1 558 JPY, Astellas Pharma Inc is Undervalued by 45%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
2 850.74 JPY
Undervaluation 45%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.5
P/S
P/S
Price to Sales
1.5
vs History
96
vs Industry
63
Median 3Y
2.5
Median 5Y
2.4
Industry
2.4
Forward
1.8
More Details
74.8
P/E
P/E
Price to Earnings
74.8
vs History
6
vs Industry
5
Median 3Y
30
Median 5Y
25.6
Industry
22.9
Forward
36.7
More Details
12.9
P/OCF
P/OCF
Price to OCF
12.9
vs History
46
vs Industry
31
Median 3Y
13.1
Median 5Y
12.3
Industry
17.1
More Details
3.5
P/FCFE
P/FCFE
Price to FCFE
3.5
vs History
96
vs Industry
35
Median 3Y
22.3
Median 5Y
16.3
Industry
23.2
More Details
1.9
P/B
P/B
Price to Book Value
1.9
vs History
96
vs Industry
43
Median 3Y
2.3
Median 5Y
2.3
Industry
2.1
More Details
1.5
EV/S
EV/S
Enterprise Value to Sales
1.5
vs History
96
vs Industry
62
Median 3Y
2.3
Median 5Y
2.2
Industry
2.6
Forward
1.9
More Details
1.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.9
vs History
96
vs Industry
73
Median 3Y
2.9
Median 5Y
2.8
Industry
5.1
More Details
10.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.8
vs History
44
vs Industry
33
Median 3Y
11.3
Median 5Y
10.5
Industry
13.6
Forward
12.1
More Details
20.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
20.9
vs History
12
vs Industry
22
Median 3Y
16.5
Median 5Y
15.2
Industry
17
Forward
10.2
More Details
13.8
EV/OCF
EV/OCF
Enterprise Value to OCF
13.8
vs History
17
vs Industry
31
Median 3Y
12.1
Median 5Y
11.7
Industry
15.8
More Details
23.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
23.7
vs History
11
vs Industry
19
Median 3Y
16.6
Median 5Y
16.5
Industry
17.6
More Details
1
EV/IC
EV/IC
Enterprise Value to IC
1
vs History
96
vs Industry
60
Median 3Y
1.7
Median 5Y
1.6
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Astellas Pharma Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Astellas Pharma Inc
TSE:4503
2.8T JPY 1.5 74.8 10.8 20.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
728.1B USD 21.3 138.7 62.7 72
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 16.9 46.8 34.2 37.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
JP
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
704.3B JPY 2.2 83.6 9.5 23.2
US
Johnson & Johnson
NYSE:JNJ
361.3B USD 4.4 8.9 11.9 15.7
US
Merck & Co Inc
NYSE:MRK
326.6B USD 5.3 141.6 33.7 53.4
UK
AstraZeneca PLC
LSE:AZN
188.2B GBP 5.1 39.5 140.7 225.7
CH
Novartis AG
SIX:NOVN
181.4B CHF 4.2 13.3 9.7 16.1
CH
Roche Holding AG
SIX:ROG
171.2B CHF 2.9 14.9 8.5 10.1

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.